Management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE guidance

  title={Management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE guidance},
  author={Lee Yee Chong and Elisabetta Fenu and Gerard P Stansby and Sarah Hodgkinson},
  journal={BMJ : British Medical Journal},
Venous thromboembolic diseases range from asymptomatic deep venous thrombosis (DVT) to fatal pulmonary embolism. Non-fatal venous thromboembolic diseases may also cause serious long term conditions such as post-thrombotic syndrome or chronic thromboembolic pulmonary hypertension. In the United Kingdom, pathways to diagnosis and to decisions on long term treatment or further investigation for thrombophilia and cancer vary, so guidance is needed in these areas. This article summarises the most… Expand
Thrombophilia evaluation in pulmonary embolism.
Thrombophilia testing in its current form does not significantly impact clinical management or improve outcomes for most VTE patients, so it should be employed judiciously and only in patients for whom it is likely to alter clinical management. Expand
Thrombophilic Evaluation in Patients with Acute Pulmonary Embolism: Controversies and Evolving Concepts in Deep Venous Thrombosis and Pulmonary Embolism
This article reviews common thrombophilias, their epidemiology and classification, and timing and technical aspects of accurate testing and provides rational suggestions for the use of thROMbophilia testing in five clinical situations. Expand
Diagnosis and management of pulmonary embolism
There is a wealth of high quality individual studies and meta-analyses to guide the diagnosis and treatment of pulmonary embolism, and an overview and synthesis of that evidence is provided in this review. Expand
Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis.
It is encouraging to note that the published data to date regarding Asian patients indicates that such new therapies are safe and efficacious, and efforts to improve outcomes in patients with DVT rely on the awareness in the scientific and medical community regarding the importance of DVT. Expand
Post-PE Management
This work hopes that it can offer a framework for post-discharge PE care by which the outpatient provider can provide a logical approach using the latest available evidence. Expand
Thrombophilia: clinical–practical aspects
  • S. Moll
  • Medicine
  • Journal of Thrombosis and Thrombolysis
  • 2015
Thrombophilia tests should only be ordered by health care professionals who can provide the “4P”: appropriately select which patient to test, provide pre-test counseling, properly interpret the test results, and provide education and advice to the patient. Expand
An Algorithmic Approach to Management of Venous Thromboembolism
  • P. Dhakal, K. Gundabolu, V. Bhatt
  • Medicine
  • Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • 2017
New oral anticoagulants such as apixaban, rivaroxaban, or dabigatran may be preferred to vitamin K antagonists in patients without cancer or renal failure after the development of reversal agents such as idarucizumab and andexanet alfa. Expand
Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.
ICD-9 codes for thrombophilia are highly specific for laboratory-confirmed cases, but all algorithms had low sensitivities. Expand
Prevention of Venous Thromboembolism in Gynecologic Surgery: ACOG Practice Bulletin, Number 232.
  • Medicine
  • Obstetrics and gynecology
  • 2021
This Practice Bulletin has been revised to reflect updated literature on the prevention of VTE in patients undergoing gynecologic surgery and the current surgical thromboprophylaxis guidelines from the American College of Chest Physicians. Expand
Evaluation of thrombophilia testing in the inpatient setting: A single institution retrospective review
A study to evaluate thrombophilia testing practices of adult patients who were admitted to Lehigh Valley Hospital at Cedar Crest with either venous thromboembolism or ischemic stroke in 2019 revealed that a majority of inpatient throm bophilia tests did not follow institutional guidelines for appropriate testing and did not change patient management. Expand


The management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE Guideline CG144.
Venous thromboembolic disease is a common presentation in acute medicine and ensuring fast, accurate diagnosis and appropriate management is important to reduce mortality and the long-term complications associated with the disease. Expand
Systematic Review: d-Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism
A systematic review and meta-analysis of studies that measured d-dimer in patients who had stopped anticoagulant therapy for a first episode of unprovoked VTE to assess the value of d-Dimer as a predictor of recurrent disease provided precise and reliable estimates of the risk for recurrent VTE. Expand
The post‐thrombotic syndrome: risk factors and impact on the course of thrombotic disease
Proximal DVT, male gender, and high D‐dimer levels are independently associated with the development of post‐thrombotic syndrome in patients with a first symptomatic DVT. Expand
Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis
In patients with a first unprovoked venous thromboembolism, men have a 2.2-fold higher risk of recurrent venousThromboEmbolism than do women, and the risk of recurrence remains 1.8-foldHigher in men after adjustment for previous hormone associated venous Thrombo Embolism in women. Expand
Predictive Value of D‐Dimer Test for Recurrent Venous Thromboembolism After Anticoagulation Withdrawal in Subjects With a Previous Idiopathic Event and in Carriers of Congenital Thrombophilia
D‐dimer levels measured 1 month after OAT withdrawal have a high negative predictive value for recurrence in subjects with unprovoked VTE who are either carriers or not carriers of congenital thrombophilia. Expand
Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis
Men seem to have a 50% higher risk than women of recurrent venous thromboembolism after stopping anticoagulant treatment, and this difference in risk of recurrence should be considered when duration of anticoagenic treatment is determined in individual patients. Expand
Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.
Deep-vein thrombosis can be ruled out in a patient who is judged clinically unlikely to have deep-veIn thromBosis and who has a negative D-dimer test, and ultrasound testing can be safely omitted in such patients. Expand
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
Women with 0 or 1 risk factor may safely discontinue oral anticoagulant therapy after 6 months of therapy following a first unprovoked venous thromboembolism, and this criterion does not apply to men. Expand
Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer.
The combination of a score < or =4.0 by the authors' simple clinical prediction rule and a negative SimpliRED D-Dimer result may safely exclude PE in a large proportion of patients with suspected PE. Expand
National Institute for Health and Clinical Excellence. The guidelines manual
  • 2009